🧬

Biyoteknoloji Sektörü Hisseleri

Biyoteknoloji Sektörü altında 614 Hisse Senedi

Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.

Biyoteknoloji Sektörü Hakkında

Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.

Temel Özellikler

  • Yüksek AR-GE yatırımları
  • Uzun geliştirme süreçleri
  • Düzenleyici onay riskleri
  • Yüksek büyüme potansiyeli

Önemli Şirketler

ModernaGilead SciencesBiogenRegeneron
100
Toplam Hisse
$70.4B
Toplam Piyasa Değeri

Biyoteknoloji Sektörü Hisseleri

Sayfa 3/7 (Toplam: 614)
SEMBOLŞİRKETPİYASA DEĞERİFİYATDEĞİŞİM
PCRXPacira BioSciences, Inc.$1.07B$23.571.01%
BHVNBiohaven Ltd.$1.06B$10.035.80%
KURAKura Oncology, Inc.$1.06B$12.141.25%
GLUEMonte Rosa Therapeutics, Inc.$1.05B$16.171.13%
OPKOPKO Health, Inc.$1.04B$1.351.12%
UPBDUpbound Group, Inc.$1.04B$17.921.86%
YEXTYext, Inc.$1.04B$8.420.12%
IARTIntegra LifeSciences Holdings Corporation$1.02B$13.120.00%
MDXGMiMedx Group, Inc.$1.02B$6.880.00%
EYPTEyePoint Pharmaceuticals, Inc.$1.02B$14.830.27%
BCAXBicara Therapeutics Inc. Common Stock$1.02B$18.562.32%
GLYCGlycoMimetics, Inc.$1.01B$15.712.76%
MRVIMaravai LifeSciences Holdings, Inc.$999.16M$3.620.55%
VERVVerve Therapeutics, Inc.$994.04M$11.130.27%
DAWNDay One Biopharmaceuticals, Inc.$974.39M$9.490.85%
MNMDMind Medicine (MindMed) Inc.$955.75M$12.654.55%
PSNLPersonalis, Inc.$952.82M$10.730.09%
AVBPArriVent BioPharma, Inc. Common Stock$946.95M$22.940.48%
NTLAIntellia Therapeutics, Inc.$942.03M$8.995.52%
SPRYARS Pharmaceuticals, Inc.$936.76M$9.540.31%
PLSEPulse Biosciences, Inc.$927.74M$13.690.73%
CDNACareDx, Inc$919.14M$17.870.34%
ARVNArvinas, Inc.$913.15M$12.571.21%
FLGTFulgent Genetics, Inc.$907.97M$29.581.89%
RZLTRezolute, Inc.$901.31M$9.721.67%
RIGLRigel Pharmaceuticals, Inc.$901.05M$50.490.92%
ERASErasca, Inc.$899.37M$3.171.28%
VIRVir Biotechnology, Inc.$892.41M$6.420.39%
VERBVerb Technology Company, Inc.$877.81M$14.502.76%
LENZLENZ Therapeutics, Inc.$851.83M$30.520.65%
ABUSArbutus Biopharma Corporation$845.61M$4.400.23%
IOVAIovance Biotherapeutics, Inc.$819.27M$2.471.23%
ALMSAlumis Inc. Common Stock$800.76M$7.670.39%
CMPXCompass Therapeutics, Inc.$800.68M$5.797.42%
ESPREsperion Therapeutics, Inc.$792.10M$4.011.52%
REPLReplimune Group, Inc.$784.40M$10.000.60%
CRMDCorMedix Inc.$772.92M$9.811.66%
GOSSGossamer Bio, Inc.$758.40M$3.340.00%
GERNGeron Corporation$753.26M$1.180.84%
KALVKalVista Pharmaceuticals, Inc.$731.40M$14.472.62%
CTMXCytomX Therapeutics, Inc.$724.90M$4.281.42%
CTKBCytek Biosciences, Inc.$722.42M$5.650.89%
LXEOLexeo Therapeutics, Inc. Common Stock$719.65M$9.862.39%
IKNAIkena Oncology, Inc.$718.82M$17.161152.55%
VTYXVentyx Biosciences, Inc.$713.23M$9.990.05%
MYGNMyriad Genetics, Inc.$711.16M$7.630.39%
KROSKeros Therapeutics, Inc.$708.61M$17.480.11%
GYREGyre Therapeutics, Inc.$704.05M$7.751.27%
PACBPacific Biosciences of California, Inc.$695.90M$2.313.56%
OMEROmeros Corporation$686.96M$9.690.62%
CRVSCorvus Pharmaceuticals, Inc.$684.51M$9.171.10%
RGNXREGENXBIO Inc.$677.79M$13.390.98%
PRMEPrime Medicine, Inc.$676.15M$3.822.96%
CGEMCullinan Oncology, Inc.$671.69M$11.373.15%
MGTXMeiraGTx Holdings plc$668.07M$8.301.22%
ORGOOrganogenesis Holdings Inc.$657.40M$5.184.43%
VSTMVerastem, Inc.$644.13M$10.640.09%
PROKProKidney Corp.$624.73M$2.224.72%
AQSTAquestive Therapeutics, Inc.$614.71M$6.190.48%
SRDXSurmodics, Inc.$614.51M$42.980.35%
EBSEmergent BioSolutions Inc.$602.90M$11.171.09%
FULCFulcrum Therapeutics, Inc.$591.98M$10.943.36%
LABStandard BioTools Inc.$576.85M$1.504.90%
MNPRMonopar Therapeutics Inc.$575.91M$86.181.35%
IRWDIronwood Pharmaceuticals, Inc.$569.38M$3.509.33%
RGLSRegulus Therapeutics Inc.$564.95M$8.160.00%
RAPTRAPT Therapeutics, Inc.$558.97M$33.801.62%
SAGESage Therapeutics, Inc.$544.94M$8.680.00%
NPCENeuroPace, Inc.$544.86M$16.360.85%
FDMT4D Molecular Therapeutics, Inc.$544.55M$11.666.10%
NAGENiagen Bioscience Inc$540.29M$6.771.74%
ANNXAnnexon, Inc.$538.18M$4.504.17%
ZIMVZimVie Inc.$535.63M$18.990.00%
DSGNDesign Therapeutics, Inc.$534.86M$9.390.21%
WOLFWolfspeed, Inc.$525.10M$20.281.07%
LXRXLexicon Pharmaceuticals, Inc.$519.66M$1.430.00%
LYELLyell Immunopharma, Inc.$509.23M$24.001.68%
ANGOAngioDynamics, Inc.$508.16M$12.400.81%
DNAGinkgo Bioworks Holdings, Inc.$507.12M$9.281.87%
WEAVWeave Communications, Inc.$497.80M$6.380.16%
DRUGBright Minds Biosciences Inc.$495.95M$70.005.80%
CYRXCryoport, Inc.$481.64M$9.620.21%
VREXVarex Imaging Corporation$479.00M$11.570.00%
ABSIAbsci Corporation$478.18M$3.182.91%
ZVRAZevra Therapeutics, Inc.$474.57M$8.431.98%
ALTAltimmune, Inc.$464.23M$5.261.74%
EOLSEvolus, Inc.$464.11M$7.161.70%
VPGVishay Precision Group, Inc.$453.38M$34.140.26%
ITOSiTeos Therapeutics, Inc.$448.68M$10.150.20%
PEPGPepGen Inc.$443.02M$6.455.83%
SGHTSight Sciences, Inc.$442.01M$8.360.36%
SIGASIGA Technologies, Inc.$433.96M$6.060.33%
ANROAlto Neuroscience, Inc.$430.27M$13.852.52%
SLDBSolid Biosciences Inc.$423.05M$5.431.31%
AKBAAkebia Therapeutics, Inc.$419.28M$1.580.63%
AURAAura Biosciences, Inc.$419.11M$6.603.45%
PRTCPureTech Health plc$403.61M$16.704.38%
LCTXLineage Cell Therapeutics, Inc.$401.41M$1.752.05%
TECXTectonic Therapeutic, Inc.$401.28M$21.440.23%
TRDAEntrada Therapeutics, Inc.$392.51M$10.271.88%
ÖncekiSayfa 3 / 7Sonraki